Navigation Links
Study Finds Children More Likely to Receive Recommended RSV Medication Doses When Administered Through Specialty Pharmacy
Date:10/20/2011

ST. PAUL, Minn., Oct. 20, 2011 /PRNewswire/ -- Children given an injectable medication to help prevent severe respiratory illness had a 17.6 percent higher likelihood of receiving the American Academy of Pediatrics (AAP) recommended doses when they were administered through a specialty pharmacy rather than a traditional pharmacy, according to a new study released today by pharmacy benefit manager Prime Therapeutics (Prime). The study will be presented today at the Academy of Managed Care Pharmacy's (AMCP) Educational Conference in Atlanta, Ga.

Palivizumab (Synagis®) is the only preventive therapy approved for respiratory syncytial virus (RSV), a severe respiratory illness that is the leading cause of bronchiolitis and pneumonia in children under one year of age. The injectable medication is given monthly to infants at high risk, and completing the course of treatment has been shown to decrease costly RSV-related hospitalizations.

Researchers from Prime and two of Prime's Blue Cross and Blue Shield clients used medical and pharmacy claims data from 2,853,925 commercially insured members in the Midwest to identify individuals with a palivizumab claim during the 2009-2010 RSV season. From this, researchers determined 445 members met the analytic criteria and 325 members utilized a specialty pharmacy – a pharmacy that includes access and support for drugs that have high acquisition costs, are difficult to manage, and present reimbursement challenges – for all doses fulfilled.

The analysis found 83.4 percent of infants and children who obtained their palivizumab from a specialty pharmacy received the recommended doses, compared to 65.8 percent who received their medication from a non-specialty pharmacy.

"RSV is a serious illness for infants and children and receiving the proper dose of palivizumab can keep children healthy and prevent unnecessary hospitalizations," said Patrick Gleason, PharmD, director of clinical outco
'/>"/>

SOURCE Prime Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Study Finds New Blood Thinning Medication, Pradaxa®, Comes at High Cost
2. DIFICID™ Demonstrated Early Superiority in the First 12 Days Compared to Vancomycin in New Analysis of Phase 3 Study Results
3. Study Sheds Light on Young Suburban Heroin Users
4. Boston Scientific Completes Enrollment in Benign Stricture Study of WallFlex® Biliary RX Stent
5. New Study Shows Neonatologists and Parents of NICU Infants Share Concern Regarding Newborn Exposure to Animal-Derived Medications
6. PLC Systems Receives FDA Approval to Commence Pivotal Study of RenalGuard in the U.S.
7. Medco, Quest Diagnostics Personalized Medicine Study Yields Additional Clues about Patient Engagement
8. Study Highlights Emerging Approaches to Medical Education in the Pharmaceutical Sector
9. Good Start Genetics to Announce Validation Study Results for its Next-Generation DNA Sequencing Platform During an Oral Presentation at the 2011 Annual Meeting of the American Society for Reproductive Medicine (ASRM)
10. Merrimack Pharmaceuticals Initiates Enrollment in a Neoadjuvant Phase 2 Study of MM-121 with Paclitaxel in HER2-negative Breast Cancer Patients
11. Study Shows That Roches Investigational Drug for Alzheimers Disease Removes Amyloid Plaques From the Brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015  ResMed Inc. (NYSE: RMD ) today announced ... the quarter was $423.0 million, a 10 percent increase compared ... increase on a constant currency basis). Net income was $91.2 ... ended December 31, 2013. Diluted earnings per share for the ...
(Date:1/22/2015)... Jan. 22, 2015  Amgen (NASDAQ: AMGN ) today announced ... financial results on Tuesday, Jan. 27, 2015, after the close of ... conference call with the investment community at 2 p.m. PT. Participating ... , chairman and chief executive officer, and other members of Amgen,s ...
(Date:1/22/2015)... 2015  Profil Institute for Clinical Research, Inc., a clinical ... today a new textbook,  Translational Research Methods for Diabetes, ... leading global scientific publisher. The textbook is ... use in early phase clinical studies of new drugs ...
Breaking Medicine Technology:ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David ... Show to bestow a Juvent Sports Achievement award upon ... McKitrick. The award commemorated and congratulated McKitrick for her ... won her first amateur tournament in 1979 and most ...
(Date:1/22/2015)... 22, 2015 For over 20 years, Dr. David ... and Vista area has treated just about every type of ... circumstances. And for those same twenty-plus years, the team at ... those injuries with the best possible doctor. With the ...
(Date:1/22/2015)... 22, 2015 Yesterday, Senator Holly ... and Kristin Olsen (R-Modesto) were honored by the ... advancing biotechnology, biomedical science, medical device and pharmaceutical ... received the “2014 Life Sciences Champion” award from ...
(Date:1/22/2015)... Payday lending practices in four southern states worsen ... to the states that permit them, according to a ... Race and Wealth. , While they generate hundreds of ... the same time substantially depress economic activity, according to ...
(Date:1/22/2015)... has released a new blog post presenting a list of vehicles ... , Some types of vehicles cannot be covered under an ... post to see if their vehicle qualifies for auto insurance coverage. ... the cars that cannot be covered by a plan. Clients have ...
Breaking Medicine News(10 mins):Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
... June 29, 2009 In the June issue of ... journal of the American Society for Gastrointestinal Endoscopy (ASGE), ... colonoscopy found a wide variation among endoscopists, though researchers ... reasons for the variation and their clinical significance. Also ...
... language development, study finds, , MONDAY, June 29 (HealthDay News) ... speech skills, UCLA researchers say, listening to what they have ... , The effect of a conversation between a child ... the effect of adult speech input alone, the researchers found. ...
... emergency departments first sites for savings measurement ... CalRHIO announced today that it has selected the RAND Corporation ... savings resulting from physicians having secure electronic access to critical ... first phase of the initiative will measure savings in emergency ...
... VANCOUVER, June 29 /PRNewswire-FirstCall/ - CRH Medical Corporation (CRM:TSX-V) ... College of Medicine in Mobile Alabama has completed ... Fellows on the non surgical removal of hemorrhoids using ... of this training program into its Fellowship Program, ...
... The July issue of European Urology , ... features an editorial by Lars Holmberg comparing the results ... Cancer (ERSPC) with the results from the Prostate, Lung, ... editorial, Professor Holmberg writes that "The studies illustrate that ...
... , JACKSONVILLE, Fla., June 29 On June ... the European Association for the Study of Diabetes investigated ... sanofi-aventis) and the development of certain malignancies. The authors ... their limited data and analyses, which precluded them from ...
Cached Medicine News:Health News:GIE: Gastrointestinal Endoscopy June issue study highlights 2Health News:GIE: Gastrointestinal Endoscopy June issue study highlights 3Health News:GIE: Gastrointestinal Endoscopy June issue study highlights 4Health News:GIE: Gastrointestinal Endoscopy June issue study highlights 5Health News:Talk With Kids, Not At Them 2Health News:Talk With Kids, Not At Them 3Health News:CalRHIO Selects RAND-USC to Evaluate Savings Resulting from Use of Statewide Health Information Exchange 2Health News:CalRHIO Selects RAND-USC to Evaluate Savings Resulting from Use of Statewide Health Information Exchange 3Health News:CRH Medical introduces non surgical hemorroid removal to Gastroenterology Fellowship program 2Health News:Prostate screening studies reviewed in European Urology July issue 2Health News:AACE Response to Insulin Glargine Cancer Risk Articles in Diabetologia 2
Sabre 180, 230V, 50Hz is a powerful niche generator....
... Excaliburplus PC, 100V, 50Hz/60Hz is the most powerful ... PTP in spray Coag. It is the only ... settings from the surgical field with a standard ... Voltage in CUT maintains minimum necessary voltage for ...
High performance capabilities in a multipurpose generator, blended cut modes, simultaneous independent coagulation, low voltage coagulation, valleylab REM safety substantially reduces the risk of pat...
The Valleylab Surgistat II generator provides exceptional performance, reliability, and safety benefits in a compact, easy to use unit....
Medicine Products: